Download PDF
Laryngorhinootologie 2013; 92(06): 381-388
DOI: 10.1055/s-0033-1341465
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Maligne Lymphome im Larynx

Malignant Lymphoma in the larynx
E. Smith
1   Sektion für Phoniatrie & Pädaudiologie, HNO Univ.-Klinik, Ulm
,
R. Rottscholl
2   Institut für Pathologie, Univ.-Klinik Ulm, Ulm
,
S. Brosch
1   Sektion für Phoniatrie & Pädaudiologie, HNO Univ.-Klinik, Ulm
,
R. Reiter
1   Sektion für Phoniatrie & Pädaudiologie, HNO Univ.-Klinik, Ulm
› Author Affiliations
Further Information

Publication History

Publication Date:
05 June 2013 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Maligne hämatologische Erkrankungen, wie das hochmaligne diffuse großzellige B-Zell Non ­Hodgkin Lymphom, das MALT Lymphom und das extramedulläre Plasmozytom manifestieren sich äußerst selten lokal im Larynx. In dieser Arbeit werden klinische Symptome, laryngoskopische Befunde, Diagnostik sowie Therapiekonzepte dieser Tumore zusammengefasst. Da klassisch pathognomonische Befunde fehlen, wird die Diagnosestellung erschwert und verzögert. Deshalb muss bei suspekten Larynxveränderungen zwingend eine bioptische Sicherung durchgeführt werden, um gegebenenfalls auch eine Lymphommanifestation auszuschließen.

Abstract

Malignant Lymphoma in the Larynx

Malignant haematological diseases such as the highly malignant diffuse large B-cell lymphoma, the MALT-lymphoma and the extramedullary plasmocytoma are seldom located in the larynx. In this review, clinical symptoms, laryngoscopic findings, further diagnostics as well as therapy concepts are presented. Diagnosis is complicated and delayed due to the absence of classical pathognomic findings. Biopsy of the affected tissue can secure a correct diagnosis and malignant haematological disease can be ruled out.

Schlüsselwörter

Larynx - Lymphome - Symptome - laryngoskopische Befunde - Diagnostik

Key words

larynx - lymphoma - symptoms - laryngoscopic findings - diagnosis
 

  • Literatur

  • 1 Storm H, Klingt A, Tryggvadottir L, Gislum M, Engholm G, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with malignant neoplasmas of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncologica 2010; 694-712
    PubMedGoogle Scholar
  • 2 Huh J. Epidemiologic overview of malignant lymphoma. Korean J Hematol 2012; 47: 92-104
    CrossrefPubMedGoogle Scholar
  • 3 Germing U, Strupp C, Kundgen A. No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 2004; 905-910
    PubMedGoogle Scholar
  • 4 Hiddemann W, Dreyling M. Epidemiologie. In Hiddenmann W, Dreyling M, Stein H. Lymphome 2004: Neue Erkenntnisse und Therapiestrategien. 2004: 1-18
    Google Scholar
  • 5 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917
    CrossrefPubMedGoogle Scholar
  • 6 Markou K, Goudakos J, Constantinidis J, Kostopoulod I, Vital V, Nikolaou A, Rosenthal E. Primary laryngeal lymphoma: Report of three cases and review of the literature. Head and Neck 2010; 541-549
    PubMedGoogle Scholar
  • 7 Cattaruzza M, Maisonneuve P, Boyle P. Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol 1996; 32: 293-305
    CrossrefPubMedGoogle Scholar
  • 8 Robert Koch Institut . Zentrum für Krebsregisterdaten: Krebs in Deutschland 2007/2008: Eine gemeinsame Veröffentlichung des Robert Koch Instituts und der Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. 2012; 108-112
    PubMedGoogle Scholar
  • 9 Koskinen WJ, Brøndbo K, Mellin Dahlstrand H, Luostarinen T, Hakulinen T, Leivo I, Molijn A, Quint WG, Røysland T, Munck-Wikland E, Mäkitie AA, Pyykkö I, Dillner J, Vaheri A, Aaltonen LM. Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol 2007; 133: 673-678
    CrossrefPubMedGoogle Scholar
  • 10 Pelucchi C, Tramacere I, Boffetta P, Negri E, La Vecchia C. Alcohol consumption and cancer risk. 2011; 63: 983-990
    PubMedGoogle Scholar
  • 11 Applebaum K, Furniss C, Zeka A, Posner M, Smith J, Bryan J, Eisen E, Peters E, Michael D, McClean M, Kelsey K. Lack of Association of Alcohol and Tobacco with HPV16-Associated Head and Neck Cancer. J Nat Cancer Inst 2007; 99: 1801-1810
    CrossrefPubMedGoogle Scholar
  • 12 Maier H, Weidauer H. Alcohol drinking and tobacco smoking are the chief risk factors for ENT tumors. Increased incidence of mouth cavity, pharyngeal and laryngeal carcinomas. Fortschr Med 1995; 113: 157-160
    PubMedGoogle Scholar
  • 13 Francis D, Maynard C, Weymuller EA, Reiber G, Merati A, Yueh B. Reevaluation of gastroesophageal reflux disease as a risk factor for laryngeal cancer. Laryngoscope 2011; 121: 102-105
    CrossrefPubMedGoogle Scholar
  • 14 Lee LA, Cheng AJ, Fang TJ, Huang CG, Lia CT, Chang JT, Li HY. High Incidence of Malignant Transformation of Laryngeal Papilloma in Taiwan. Laryngoscope 2008; 118: 50-55
    CrossrefPubMedGoogle Scholar
  • 15 Opie J. Haematological complications of HIV infection. S Afr Med J 2012; 102: 465-468
    PubMedGoogle Scholar
  • 16 Kanda J, Matsuo K, Suzuki T, Hosono S, Ito H, Ichinohe T, Seto M, Morishima Y, Tajima K, Tanaka H. Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. Int J Cancer 2010; 126: 2416-2425
    PubMedGoogle Scholar
  • 17 Chihara D, Ito H, Katanoda K, Shibata A, Matsuda T, Tajima K, Sobue T, Matsuo K. Increase in incidence of adult T-cell leukemia/lymphoma in non-endemic areas of Japan and the United States. Cancer Sci 2012; 103: 1857-1860
    CrossrefPubMedGoogle Scholar
  • 18 Becker M, Burkhardt K, Dulguerov P, Allal A. Imaging of the larynx and hypopharynx. Eur J Radiol 2008; 66: 460-479
    CrossrefPubMedGoogle Scholar
  • 19 Rücker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Fröhling S, Bentz M, Miller S, Scholl C, Schlenk RF, Radlwimmer B, Kestler HA, Pollack JR, Lichter P, Döhner K, Döhner H. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterisation. J Clin Oncol 2006; 20: 3887-3894
    PubMedGoogle Scholar
  • 20 Cerhan JR. Host genetics in follicular lymphoma. Best Practice and Research Clinical Haematology 2011; 24: 121-134
    CrossrefPubMedGoogle Scholar
  • 21 Rajkumar S. Multiple myeloma: 2012 update on diagnosis, risk-stratification and management. Annual clinical updates in haematological malignacies: A continuing medical education series. American J Hematology 2012; 79-88
    PubMedGoogle Scholar
  • 22 Campo E, Swerdlow S, Harris N, Pileri S, Stein H, Jaffe E. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011; 117: 5019-5032
    CrossrefPubMedGoogle Scholar
  • 23 Dürkop H, Foss HD, Stein H. 2008-WHO-Klassifikation der maligne Lymphome im Jahr 2011. Neue Erkenntnisse und praktische Anwendung. Onkologe 2011; 769-788
    PubMedGoogle Scholar
  • 24 Horny HP. The larynx in lymphoproliferative and myeloproliferative diseases. Part II: Laryngeal autopsy findings and discussion. HNO 1994; 42: 398-404
    PubMedGoogle Scholar
  • 25 de Bree R, Mahieu HF, Ossenkoppele GJ, van der Valk P. Malignant lymphoma of mucosa-associated lymphoid tissue in the larynx. Eur Arch Otorhinolaryngol 1998; 255: 368-370
    CrossrefPubMedGoogle Scholar
  • 26 Kuo J, Hou Y, Chu S, Chien C. Subglottic stenosis induced by extranodal mucosa associated lymphoid tissue lymphoma. Journal of the Chinese medical association 2011; 74: 144-147
    CrossrefPubMedGoogle Scholar
  • 27 Uri N, Schindler Y, Quitt M, Valkovsky O, Barzilai G. Primary NK/T-cell lymphoma of the larynx. Ear Nose Throat J 2012; 91: 206-207
    PubMedGoogle Scholar
  • 28 Andratschke M, Stelter K, Ihrler S, Hagedorn S. Subglottic tracheal stenosis as primary manifestation of a marginal zone B-cell lymphoma of the larynx. In vivo 2005; 1: 547-550
    PubMedGoogle Scholar
  • 29 Yilmaz M, Ibrahimov M, Mamanov M, Rasidov R, Oktem F. Primary marginal zone B-cell lymphoma of the larynx. J Craniofac Surg 2012; 23: 1-2
    CrossrefPubMedGoogle Scholar
  • 30 Wright D. Pathology of Extra-nodal non Hodgkin Lymphomas. Clinical Oncology. Overview 2012; 24: 319-328
    PubMedGoogle Scholar
  • 31 Howell JM, Auer-Grzesiak I, Zhang J, Andrews CN, Stewart D, Urbanski SJ. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population. Can J Gastroenterol 2012; 26: 452-456
    PubMedGoogle Scholar
  • 32 Vega F, Lin P, Medeiros L. Extranodal lymphomas of the head and neck. Ann Diagn Pathol 2005; 9: 340-350
    CrossrefPubMedGoogle Scholar
  • 33 Zhou J, Wei L, Cao Y. Analysis on clinical and immunohistochemical characteristics of primary extranodular non-Hodgkin’s lymphoma in otolaryngol head and neck. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2003; 17: 724-726
    PubMedGoogle Scholar
  • 34 Ezzat AA, Ibrahim EM, El Weshi AN, Khafaga YM, AlJurf M, Martin JM, Ajarim DS, Bazarbashi SN, Stuart RK, Zucca E. Localized non-Hodgkin’s lymphoma of Waldeyer’s ring: clinical features, management, and prognosis of 130 adult patients. Head and Neck 2001; 23: 547-558
    CrossrefPubMedGoogle Scholar
  • 35 Jacobs C, Hoppe R. Non-Hodgkin’s lymphomas of head and neck extranodal sites. International Journal of Radiation Oncology Biology Physics 1985; 11: 357-364
    CrossrefPubMedGoogle Scholar
  • 36 Özdemir S, Tarkan O, Tuncer U, Sürmelioğlu O, Doğrusöz M, Ergin M. A case of extramedullary plasmacytoma in the sphenoid sinus with unilateral loss of vision. J Craniomaxillofac Surg 2012; 41: 140-143
    PubMedGoogle Scholar
  • 37 Gouveris H, Hansen T, Franke K. Solitary extramedullary plasmacytoma and granulomatous sialadenitis of the parotid gland preceding a B-cell non-Hodgkin’s lymphoma. Mund-Kiefer-Gesichtschir 2006; 10: 122-125
    PubMedGoogle Scholar
  • 38 Schmoll H-J, Höffken K, Possinger K. Kompendium Internistische Onkologie: Epidemiologie, Tumorbiologie, Zytostatika, Prinzipien der Tumortherapie, Supportive Maßnahmen. Therapiekonzepte maligner Tumoren. Band 1. Maligne Lymphome HNO Bereich 2005; 64
    PubMedGoogle Scholar
  • 39 Tutalel O, Barg-Hock H, Pischke S, Bahr M, Kreipe H, Greten T, Manns M, Strassburg C. Mycosis fungoides with involvement of the larynx after liver transplantation in an adult. Am J Gastroenterol 2010; 238-240
    PubMedGoogle Scholar
  • 40 Salazar Guilarte JX, Sancho Mestre M, Gras Albert JR. Laryngeal manifestation of B-cell non-Hodgkin lymphoma. Acta Otorrinolaringol Esp 2012; 63: 485-487
    CrossrefPubMedGoogle Scholar
  • 41 Padhi S, Paul TR, Challa S, Prayaga AK, Rajappa S, Raghunadharao D, Sarangi R. Primary extra nodal non hodgkin lymphoma: a 5 year retrospective analysis. Asian Pac J Cancer Prev 2012; 13: 4889-4895
    CrossrefPubMedGoogle Scholar
  • 42 Franzen A, Kurrer M. Das maligne Lymphom des Larynx: Fallbericht und Literaturübersicht. Laryngorhinootology 2000; 79: 579-583
    PubMedGoogle Scholar
  • 43 Mokhtar N. Review article. Composite Lymphoma, Journal of the Egyptian Nat. Cancer Inst 2007; 19: 171-175
    PubMedGoogle Scholar
  • 44 Cui W, Fan F, Zhang D, Garnett D, Tilzer L. Primary composite lymphoma of the larynx, composed of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, presenting as left subglottic tracheal fistula, esophageal diverticulum and neck abscess. Ann Clin Lab Sci 2012; 42: 73-80
    PubMedGoogle Scholar
  • 45 Zhao K, Luo Y-Z, Zhou S-H, Dai B-L, Luo X-M, Yan S-X, Wang Q-Y, Ling L. 18 F-fluordeoxyglucose positron emisson tomography/computed tomography findings in mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review. J Int Med Res 2012; 1192-1206
    PubMedGoogle Scholar
  • 46 Fischer M, Horn I, Bertolini J, Fuchs M, Dietz A. MALT-Lymphom des Larynx bei bekanntem Sjögrensyndrom. HNO 2011; 111-114
    PubMedGoogle Scholar
  • 47 Zucca E, Gregorini A, Cavalli F. Management of non-Hodgkin lymphomas arising at extranodal sites. Ther Umsch 2010; 67: 517-525
    CrossrefPubMedGoogle Scholar
  • 48 Kiesewetter B, Troch M, Müllauer L, Raderer M. Running in the family: MALT lymphoma and autoimmune disease in mother and daughter. World J Gastrointest Oncol 2012; 26-29
    PubMedGoogle Scholar
  • 49 Fischer D, Bärmann M, Stasche N. Dreifachmanifestation eines extramedullären Plasmozytoms im HNO Bereich – Ein Fallbericht. Laryngo-Rhino-Otol 2007; 48-50
    PubMedGoogle Scholar
  • 50 Robert Koch Institut . und Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. 2012: Gesundheitsberichterstattung des Bundes. Zentrum für Krebsregisterdaten: Krebs in Deutschland 2007/2008 2012; 104-116
    PubMedGoogle Scholar
  • 51 Straetmans J, Strokroos R. Extramedullary plasmocytomas in the head and neck region. Eur Arch Otorhinolaryngol 2008; 265: 1417-1423
    CrossrefPubMedGoogle Scholar
  • 52 Pasmantier M, Azr H. Extrasceletal spread in multiple plasma cell myeloma, a review of 57 autopsied cases. Cancer 1969; 167-175
    PubMedGoogle Scholar
  • 53 Varettoni M, Coreso A, Pica G. Incidence presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol 2009; 325-330
    PubMedGoogle Scholar
  • 54 Stering A, Aviel-Ronen S, Schiby G, Bedrin L, Talmi Y. Coexistent chronic lymphocytic leukemia and squamous cell carcinoma of the larynx. Ear Nose Throat J 2008; 87: 1-3
    PubMedGoogle Scholar
  • 55 Hammami B, Mnejja M, Achour I, Chakroun A, Khabir A, Chakroun A, Boudawara T, Charfeddine I, Ghorbel A. Association of squamous cell carcinoma of the larynx and chronic lymphoid leukemia. Eur Ann Otorhinolaryngol Head Neck Dis 2010; 127: 153-155
    CrossrefPubMedGoogle Scholar
  • 56 Ozçelik T, Ali R, Ozkalemkaş F, Ozkocaman V, Coşkun H, Erişen L, Filiz G. A case of granulocytic sarcoma during complete remission of acute myeloid leukemia with multiple masses involving the larynx and nasopharynx. Kulak Burun Bogaz Ihtis Derg 2003; 11: 183-188
    PubMedGoogle Scholar
  • 57 Vassallo J, Altemani A, Cardinalli I, Crespo A, Lima C, Eid K, Souza C. Granulocytic sarcoma of the larynx preceding chronic myeloid leukemia. Pathol Res Pract 1993; 189: 1084-1089
    CrossrefPubMedGoogle Scholar
  • 58 Welch AR, Barton RP. Laryngeal obstruction – a rare presentation of leukaemia. J Laryngol Otol 1984; 98: 327-329
    CrossrefPubMedGoogle Scholar
  • 59 Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren’s syndrome: a community-based study of prevalence and impact. Rheumatology 1998; 37: 1069-1076
    CrossrefPubMedGoogle Scholar
  • 60 Liew MSH, Zhang M, Kim E, Akpek EK. Prevalence and predictors of Sjögren’s syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol 2012; 1498-1503
    PubMedGoogle Scholar
  • 61 Feist E, Dörner T, Hansen A. Indications and options of new immune modulatory therapies for Sjögren’s syndrome. Z Rheumatol 2007; 66: 679-685
    CrossrefPubMedGoogle Scholar
  • 62 Pras E. Lymphorna in Sjögren’s syndrome. In: Klippel JH, Dieppe PA. (eds.): Rheumatology. Mosby; London, Philadelphia: 1998. 7. 1-7
    Google Scholar
  • 63 Kassan SS, Thomas TI, Moutsopoulos HM, Hoover RP, Kimberley DR, Budman J, Costa JL, Decker TM. Chused: Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978; 888-892
    PubMedGoogle Scholar
  • 64 Anonapaulos AP, Tiniakou M, Melachrinou M, Sfountouris H, Bounas A, Zervas C, Zoumbos NC. Sjögren’s syndrome in patients with newly diagnosed untreated non-Hodgkin’s lymphoma. Rev Rhum Engl Ed 1997; 287-297
    PubMedGoogle Scholar
  • 65 Nagasaka T, Lai R, Kuno K, Nakashima T, Nakashima N. Localized amyloidosis and extramedullary plasmocytoma involving the larynx of a child. Hum Pathol 2001; 32: 132-134
    CrossrefPubMedGoogle Scholar
  • 66 Telio D, Bailey D, Chen C, Crump M, Reece D, Kukreti V. Two distinct syndromes of lymphoma-associated AL amyloidosis: a case series and review of the literature. Am J Hematol 2010; 85: 805-808
    CrossrefPubMedGoogle Scholar
  • 67 Ma L, Bandarchi B, Sasaki C, Levine S, Choi Y. Primary localized laryngeal amyloidosis: report of 3 cases with long-term follow-up and review of the literature. Arch Pathol Lab Med 2005; 129: 215-218
    PubMedGoogle Scholar
  • 68 Wierzbicka M, Budzyński D, Piwowarczyk K, Bartochowska A, Marszałek A, Szyfter W. How to deal with laryngeal amyloidosis? Experience based on 16 cases. Amyloid 2012; 24
    PubMedGoogle Scholar
  • 69 Gilad R, Milillo P, Som PM. Severe diffuse systemic amyloidosis with involvement of the pharynx, larynx, and trachea: CT and MR findings. Am J Neuroradiol 2007; 28: 1557-1558
    CrossrefPubMedGoogle Scholar
  • 70 Bartels H, Dikkers FG, van der Wal JE, Lokhorst HM, Hazenberg BP. Laryngeal amyloidosis: localized versus systemic disease and update on diagnosis and therapy. Ann Otol Rhinol Laryngol 2004; 113: 741-748
    CrossrefPubMedGoogle Scholar
  • 71 Velez D, Hinojar-Gutierrez A, Nam-Cha S, Acevedo-Barbera A. Laryngeal plasmacytoma presenting as amyloid tumour: a case report. Eur Arch Otorhinolaryngol 2007; 264: 959-961
    CrossrefPubMedGoogle Scholar
  • 72 Michl M. BASICS Hämatologie. Urban & Fischer 2010; 1-176
    PubMedGoogle Scholar
  • 73 Cavalot A, Preti G, Vione N, Nazional G, Palonta F, Fadda G. Isolated primary non-Hodgkin’s malignant lymphoma of the larynx. J Laryngol Otol 2001; 115: 324-326
    PubMedGoogle Scholar
  • 74 Puig Garcews P, Martinez Beneito P, Piles Galdon A, Serrano Badia E, Perez Garrigues T. Subglottic MALT-type lymphoma: unusual location. Acta Otorhinolaryngol Esp 2002; 53: 693-696
    PubMedGoogle Scholar
  • 75 Siddiqui NA, Branstetter 4th BF, Hamilton BE, Ginsberg LE, Glastonbury CM, Harnsberger HR, Barnes EL, Myers EN. Imaging characteristics of primary laryngeal lymphoma. Am J Neuroradiol 2010; 31: 1261-1265
    CrossrefPubMedGoogle Scholar
  • 76 Jerusalem GH, Beguin YP. Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. Clin Lymphoma 2002; 3: 56-61
    PubMedGoogle Scholar
  • 77 Uffmann M, Schaefer-Prokop C. Radiological diagnostics of Hodgkin- and non-Hodgkin lymphomas of the thorax. Radiologe 2004; 44: 444-456
    CrossrefPubMedGoogle Scholar
  • 78 Solans-Laqué R, Bosch-Gil J, Canela M, Lorente J, Pallisa E, Vilardell-Tarrés M. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener’s granulomatosis. Lupus 2008; 17: 832-836
    CrossrefPubMedGoogle Scholar
  • 79 Ruback MJ, Galbiatti AL, Arantes LM, Marucci GH, Russo A, Ruiz-Cintra MT, Raposo LS, Maniglia JV, Pavarino EC, Goloni-Bertollo EM. Clinical and epidemiological characteristics of patients in the head and neck surgery department of a university hospital. Sao Paulo Med J 2012; 130: 307-313
    CrossrefPubMedGoogle Scholar
  • 80 Reiter R, Rettinger G, Veit J, Pilcher C, Brosch S. Chondrosarkom des Larynx nach Stimmlippenaugmentation mit Teflon. Laryngo-Rhino-Otol 2012; 91: 644-645
    PubMedGoogle Scholar
  • 81 Tashima L, Mitzner R, Durvesh S, Goldenberg D. Dyspnea as a prognostic factor in anaplastic thyroid carcinoma. Eur Arch Otorhinolaryngol 2012; 269: 1251-1255
    CrossrefPubMedGoogle Scholar
  • 82 Alexiou C, Kau R, Dietzfelbinger H, Kremer M, Spieß J, Schratzenstaller B, Arnold W. Extramedullary plasmocytoma: tumor occurence and therapeutic concepts. Cancer 1999; 2305-2314
    PubMedGoogle Scholar
  • 83 Dimopoulos MA, Hamilos G. Solitary bone plasmacytoma and extramedullary plasmacytoma. Curr Treat Options Oncol 2002; 3: 255-259
    CrossrefPubMedGoogle Scholar
  • 84 Sakiyama S, Kondo K, Mitsuteru Y, Takizawa H, Kanzaki K, Miyoshi T, Masahiro A, Wakatsuki S, Monden Y. Extramedullary plasmacytoma immunoglobulin D in the chest wall and the subglottic region, Brief communications. The journal of thoracic and cardiovascular surgery 2005; 1168-1169
    PubMedGoogle Scholar
  • 85 Oriol A. Multiple myeloma with extramedullary disease. Adv Ther 2011; 28: 1-6
    PubMedGoogle Scholar
  • 86 Japan Lymphoma Radiation Therapy Group (JLRTG) . Oguchi M, Ikeda H, Isobe K, Hirota S, Hasegawa M, Nakamura K, Sasai K, Hayabuchi N. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin’s lymphoma: a survey of the Japan lymphoma radiation therapy group Original Research Article International. Journal of Radiation Oncology/Biology/Physics 2000; 1: 161-168
    PubMedGoogle Scholar